<DOC>
	<DOCNO>NCT00270140</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness epoetin alfa dose 150 , 300 , 600 unit per kilogram body weight versus placebo facilitate presurgical collection blood self-donation surgery knee , hip spine . Epoetin alfa genetically engineer protein stimulates red blood cell production .</brief_summary>
	<brief_title>A Study Evaluate Safety Effectiveness Epoetin Alfa Versus Placebo Facilitating Presurgical Collection Blood Used Self-donation During Surgery Spine , Hip , Knee .</brief_title>
	<detailed_description>Major surgical procedure may require transfusion several unit blood . Blood transfusion people may associate transfusion reaction cause fever viral infection carry ( donate ) blood . However , self-donations blood may cause anemia patient undergo surgery week later . Previous research epoetin alfa suggest epoetin alfa speed rate red blood cell production beneficial effect anemia . This randomized , double-blind , placebo-controlled , multicenter study design determine whether treat patient epoetin alfa stimulate person 's bone marrow produce red blood cell therefore increase patient 's ability self-donate blood prior major surgery joint disease . Patients randomly assign receive 150 , 300 , 600 unit epoetin alfa per kilogram body weight , match placebo , inject vein first study day , every 3 4 day thereafter 21 day . Effectiveness determine number unit blood donate patient study , number unit non-self-donated blood use surgery , total red cell volume self-donated blood , total red cell production , percentage sub-standard unit blood self-donated . Safety evaluation include incidence adverse event , physical examination , clinical laboratory test perform throughout study . The study hypothesis patient treat epoetin alfa able donate unit blood patient receive placebo . Epoetin alfa , 150 , 300 , 600 unit per kilogram body weight , placebo , inject vein every three four day 21 day ( 6 dos ) period surgery .</detailed_description>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Patients schedule surgery knee , hip , spine 25 35 day start epoetin alfa therapy hematocrit ( percentage red cell blood ) &gt; 39 percent &lt; =50 percent good general health Patients history primary blood disease history artery blockage heart , body brain , history seizure uncontrolled high blood pressure , folate deficiency , vitamin B12 deficiency iron deficiency anemia , active inflammatory disease ( except osteoarthritis rheumatoid arthritis ) disease destroy blood cell lose blood stomach , intestine elsewhere body received therapy drug know affect red blood cell formation ( chemotherapy cancer )</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>anemia</keyword>
	<keyword>blood transfusion</keyword>
	<keyword>epoetin alfa</keyword>
	<keyword>erythropoietin</keyword>
	<keyword>surgery</keyword>
	<keyword>blood donation</keyword>
	<keyword>blood</keyword>
</DOC>